National Medical Research Center for Cardiology, Moscow (Russian Federation)
Follow
Contributor content
Presentation
The synthetic glucagon-like peptide-1 receptor agonist liraglutide affects the kinetics of pro-inflammatory kinases and improves insulin sensitivity of 3T3-L1 adipocytes
